Aurelien Valet active positions
Companies | Position | Start | End |
---|---|---|---|
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Director/Board Member | 2005-08-31 | - |
Founder | 2005-08-31 | - |
Career history of Aurelien Valet
Former positions of Aurelien Valet
Companies | Position | Start | End |
---|---|---|---|
Biologics 4 Life SAS
Biologics 4 Life SAS Pharmaceuticals: MajorHealth Technology Part of Graftys SA, Biologics 4 Life SAS develops injectable biomaterials to treat and prevent fractures caused by osteoporosis. The company is based in Jouques, France. The French company was founded in 2018 by Aurelien Valet, Alain Valet, Sébastien Genesta. Biologics 4 Life was acquired by Graftys SA on November 08, 2021. | Founder | 2017-12-31 | 2021-10-31 |
President | 2017-12-31 | 2021-10-31 |
Statistics
International
France | 3 |
Operational
Founder | 2 |
Director/Board Member | 1 |
President | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Health Technology |
Biologics 4 Life SAS
Biologics 4 Life SAS Pharmaceuticals: MajorHealth Technology Part of Graftys SA, Biologics 4 Life SAS develops injectable biomaterials to treat and prevent fractures caused by osteoporosis. The company is based in Jouques, France. The French company was founded in 2018 by Aurelien Valet, Alain Valet, Sébastien Genesta. Biologics 4 Life was acquired by Graftys SA on November 08, 2021. | Health Technology |
- Stock Market
- Insiders
- Aurelien Valet
- Experience